Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation

References

• Abdel-Aziz RT, Aly UF, Mady FM. (2021). Enhanced skin delivery of propranolol HCl using nonionic surfactant-based vesicles for topical treatment of infantile hemangioma. J Drug Deliv Sci Technol 61:102235.
   Web of Science ®Google Scholar
• Abdelbari MA, El-Mancy SS, Elshafeey AH, Abdelbary AA. (2021). Implementing spanlastics for improving the ocular delivery of clotrimazole: in vitro characterization, ex vivo permeability, microbiological assessment and in vivo safety study. Int J Nanomed 16:6249–61.
   PubMed Web of Science ®Google Scholar
• Abdellatif MM, Khalil IA, Elakkad YE, et al. (2020). Formulation and characterization of sertaconazole nitrate mucoadhesive liposomes for vaginal candidiasis. Int J Nanomed 15:4079–90.
   PubMed Web of Science ®Google Scholar
• Abdelmonem R, Elhabal SF, Abdelmalak NS, et al. (2021). Formulation and characterization of acetazolamide/carvedilol niosomal gel for glaucoma treatment: in vitro, and in vivo study. Pharmaceutics 13:221.
   PubMed Web of Science ®Google Scholar
• Abdelmonem R, Hamed RR, Abdelhalim SA, et al. (2020). Formulation and characterization of cinnarizine targeted aural transfersomal gel for vertigo treatment: a pharmacokinetic study on rabbits. IJN 15:6211–23.
   Google Scholar
• Al-mahallawi AM, Ahmed D, Hassan M, El-Setouhy DA. (2021). Enhanced ocular delivery of clotrimazole via loading into mucoadhesive microemulsion system: in vitro characterization and in vivo assessment. J Drug Deliv Sci Technol 64:102561.
   Web of Science ®Google Scholar
• Albash R, Abdelbary AA, Refai H, El-Nabarawi MA. (2019). Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation. Int J Nanomed 14:1953–68.
   PubMed Web of Science ®Google Scholar
• Alshweiat A, Csóka II, Tömösi F, et al. (2020). Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of Loratadine: preparation, characterization, and in vivo evaluation. Int J Pharm 579:119166.
   PubMedGoogle Scholar
• Ammar HO, Ghorab MM, Saleh MS, Ghoneim AM. (2021). Olanzapine mesoporous nanostructured lipid carrier: optimization, characterization, in vivo assessment, and physiologically based pharmacokinetic modeling. IEEE Trans Nanobiosci 20:166–74.
   PubMed Web of Science ®Google Scholar
• Azevedo MA, Cerqueira MA, Fuciños P, et al. (2021). Rhamnolipids-based nanostructured lipid carriers: effect of lipid phase on physicochemical properties and storage. Food Chem 344:128670.
   PubMed Web of Science ®Google Scholar
• Badr-eldin SM, Aldawsari HM, Alhakamy NA, et al. (2022). Merging experimental design and nanotechnology for the development of optimized simvastatin spanlastics: a promising combined strategy for augmenting the suppression of various human cancer cells. Pharmaceutics 14:1024.
   PubMed Web of Science ®Google Scholar
• Ban J, Zhang Y, Huang X, et al. (2017). Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone. Int J Nanomed 12:1329–39.
   PubMed Web of Science ®Google Scholar
• Bertoni S, Passerini N, Albertini B. (2020). Nanomaterials for oral drug administration. In Nanotechnology for Oral Drug Delivery, 27–76. Academic Press. Elsevier Inc.
   Google Scholar
• Bondre RM, Kanojiya PS, Wadetwar RN, Kangali PS. (2021). Sustained vaginal delivery of in situ gel containing Voriconazole nanostructured lipid carrier: formulation, in vitro and ex vivo evaluation. J Dispers Sci Technol 0:1–13.
   Google Scholar
• Brito Raj S, Chandrasekhar KB, Reddy KB. (2019). Formulation, in-vitro and in-vivo pharmacokinetic evaluation of simvastatin nanostructured lipid carrier loaded transdermal drug delivery system. Futur J Pharm Sci 5:1–14.
   Web of Science ®Google Scholar
• Cirri M, Maestrelli F, Nerli G, et al. (2021). Development of a cyclodextrin-based mucoadhesive-thermo-sensitive in situ gel for clonazepam intranasal delivery. Pharmaceutics 13:969.
   PubMed Web of Science ®Google Scholar
• Czajkowska-Kośnik A, Szymańska E, Czarnomysy R, et al. (2021). Nanostructured lipid carriers engineered as topical delivery of etodolac: optimization and cytotoxicity studies. Materials (Basel) 14:596.
   PubMed Web of Science ®Google Scholar
• Danthuluri V, Grant MB. (2020). Update and recommendations for ocular manifestations of COVID-19 in adults and children: a narrative review. Ophthalmol Ther 9:853–75.
   PubMed Web of Science ®Google Scholar
• Dave RS, Goostrey TC, Ziolkowska M, et al. (2021). Ocular drug delivery to the anterior segment using nanocarriers: a mucoadhesive/mucopenetrative perspective. J Control Release 336:71–88.
   PubMed Web of Science ®Google Scholar
• Duong VA, Nguyen TTL, Maeng HJ. (2020). Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules 25:4781.
   PubMed Web of Science ®Google Scholar
• Durgun ME, Kahraman E, Hacıoğlu M, et al. (2022). Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies. Drug Deliv Transl Res 12:662–75.
   PubMed Web of Science ®Google Scholar
• El-Emam GA, Girgis GNS, Hamed MF, et al. (2021). Formulation and pathohistological study of mizolastine–solid lipid nanoparticles–loaded ocular hydrogels. Int J Nanomed 16:7775–99.
   PubMed Web of Science ®Google Scholar
• Eldesouky LM, El-Moslemany RM, Ramadan AA, et al. (2021). Cyclosporine lipid nanocapsules as thermoresponsive gel for dry eye management: promising corneal mucoadhesion, biodistribution and preclinical efficacy in rabbits. Pharmaceutics 13:360.
   PubMed Web of Science ®Google Scholar
• Elfadl AA, Boughdady M, Meshali M. (2021). New peceolTM/spanTM 60 niosomes coated with chitosan for candesartan cilexetil: perspective increase in absolute bioavailability in rats. Int J Nanomed 16:5581–601.
   PubMed Web of Science ®Google Scholar
• Elsayed I, Sayed S. (2017). Tailored nanostructured platforms for boosting transcorneal permeation: box-behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization. Int J Nanomed 12:7947–62.
   PubMed Web of Science ®Google Scholar
• Emami MS, Haghshenasfard M, Zarghami R, et al. (2020). Experimental study on the reduction of Loratadine particle size through confined liquid impinging jets. Int J Pharm 587:119668.
   PubMedGoogle Scholar
• Farquharson A, Gladding Z, Ritchie G, et al. (2021). Drug content uniformity: quantifying Loratadine in tablets using a created Raman excipient spectrum. Pharmaceutics 13:309–10.
   PubMed Web of Science ®Google Scholar
• Fathalla D, Soliman GM, Fouad EA. (2015). Development and in vitro/in vivo evaluation of liposomal gels for the sustained ocular delivery of latanoprost. J Clin Exp Ophthalmol 06.
   Google Scholar
• Gautam D, Chaurasia H, Singh R. (2022). Design and optimization of lomefloxacin loaded NLC gel for ophthalmic drug delivery. IJHS 6:7022–44.
   Google Scholar
• Ghanem HA, Nasr AM, Hassan TH, et al. (2021). Comprehensive study of atorvastatin nanostructured lipid carriers through multivariate conceptualization and optimization. Pharmaceutics 13:178.
   PubMed Web of Science ®Google Scholar
• Gilani SJ, Bin-Jumah M, Rizwanullah M, et al. (2021a). Chitosan coated luteolin nanostructured lipid carriers: optimization, in vitro-ex vivo assessments and cytotoxicity study in breast cancer cells. Coatings 11:158.
   Web of Science ®Google Scholar
• Gilani SJ, Bin-jumah MN, Imam SS, et al. (2021b). Formulation and optimization of nano lipid based oral delivery systems for arthritis. Coatings 11:548.
   Web of Science ®Google Scholar
• Gilani SJ, Nasser M, Zafar A, et al. (2022). Formulation and evaluation of nano lipid carrier-based ocular gel system: optimization to antibacterial activity. Gels 8:255.
   Google Scholar
• Gurumukhi VC, Bari SB. (2021). Quality by design (QbD) – based fabrication of atazanavir ‑ loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies. Drug Deliv Transl Res 12:1230–52.
   PubMed Web of Science ®Google Scholar
• Hajjar B, Zier KI, Khalid N, et al. (2018). Evaluation of a microemulsion-based gel formulation for topical drug delivery of diclofenac sodium. J Pharm Investig 48:351–62.
   Google Scholar
• Hassan DH, Abdelmonem R, Abdellatif MM. (2018). Formulation and characterization of carvedilol leciplex for glaucoma treatment: in-vitro, ex-vivo and in-vivo study. Pharmaceutics 10:197.
   PubMed Web of Science ®Google Scholar
• Hoogewoud F, Wolfensberger TJ, Guex-Crosier Y. (2021). Ocular manifestations of COVID-19. Rev Med Suisse 17:206–8.
   PubMedGoogle Scholar
• Hosny KM, Sindi AM, Ali S, et al. (2022). Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis. Drug Deliv 29:254–62.
   PubMed Web of Science ®Google Scholar
• Houacine C, Adams D, Singh KK. (2020). Impact of liquid lipid on development and stability of trimyristin nanostructured lipid carriers for oral delivery of resveratrol. J Mol Liq 316:113734.
   Web of Science ®Google Scholar
• Iqbal MA, Md S, Sahni JK, et al. (2012). Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target 20:813–30.
   PubMed Web of Science ®Google Scholar
• Kalam MA, Iqbal M, Alshememry A, et al. (2022). Development and evaluation of chitosan nanoparticles for ocular delivery of tedizolid phosphate. Molecules 27:2326.
   PubMed Web of Science ®Google Scholar
• Kar N, Chakraborty S, De AK, et al. (2017). Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes. Eur J Pharm Sci 104:196–211.
   PubMed Web of Science ®Google Scholar
• Karimi Khorrami N, Radi M, Amiri S, McClements DJ. (2021). Fabrication and characterization of alginate-based films functionalized with nanostructured lipid carriers. Int J Biol Macromol 182:373–84.
   PubMed Web of Science ®Google Scholar
• Krambeck K, Silva V, Silva R, et al. (2021). Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil. Int J Pharm 600:120444.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Chetty CM, Reddy YD, et al. (2019). Formulation and in vitro characterization of ocular in situ gels of valcyclovir. J Pharm Sci Res 11:2974–9.
   Google Scholar
• Li J, Zhou Y, Aisha M, et al. (2021). Preparation of LORATADINE nanocrystal tablets to improve the solubility and dissolution for enhanced oral bioavailability. J Pharm Pharmacol 73:937–46.
   Google Scholar
• Soliman M, Mosallam S, Mamdouh S, et al. (2022). Design and optimization of cranberry extract loaded bile salt augmented liposomes for targeting of MCP-1/STAT3/VEGF signaling pathway in DMN-intoxicated liver in rats. Drug Deliv 29:427–39.
   PubMed Web of Science ®Google Scholar
• Ma Y, Yang J, Zhang Y, et al. (2022). Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation. Drug Deliv 29:111–27.
   PubMed Web of Science ®Google Scholar
• Madan JR, Khobaragade S, Dua K, Awasthi R. (2020). Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast. Dermatol Ther 33:1–13.
   Web of Science ®Google Scholar
• Mamatha K, Srinivasarao MD, Venkatesh P. (2022). A review on:mucoadhesive drug delivery systems. J Inn App Pharma Sci 7:32–6.
   Google Scholar
• Mazyed EA, Abdelaziz AE. (2020). Fabrication of transgelosomes for enhancing the ocular delivery of acetazolamide: statistical optimization, in vitro characterization, and in vivo study. Pharmaceutics 12:465–97.
   PubMed Web of Science ®Google Scholar
• McGuckin MB, Wang J, Ghanma R, et al. (2022). Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes. J Control Release 345:334–53.
   PubMed Web of Science ®Google Scholar
• Ming H, Ho K, Craig DQM, Day RM. (2022). Design of experiment approach to modeling the effects of formulation and drug loading on the structure and properties of therapeutic nanogels. Mol Pharm 19:602–15.
   PubMedGoogle Scholar
• Mishra A, Imam SS, Aqil M, et al. (2016). Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation. Drug Deliv 23:1486–94.
   PubMed Web of Science ®Google Scholar
• Mosallam S, Ragaie MH, Moftah NH, et al. (2021). Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: in vitro characterization, in vivo assessment and exploratory clinical experimentation. Int J Nanomed 16:119–32.
   PubMed Web of Science ®Google Scholar
• Nasiri N, Sharifi H, Bazrafshan A, et al. (2021). Ocular manifestations of COVID-19: a systematic review and meta-analysis. J Ophthalmic Vis Res 16:103–12.
   PubMed Web of Science ®Google Scholar
• Nayak D, Tippavajhala VK. (2021). A comprehensive review on preparation, evaluation and applications of deformable liposomes. Iran J Pharm Res 20:186–205.
   PubMed Web of Science ®Google Scholar
• Osanlou R, Emtyazjoo M, Banaei A, et al. (2022). Preparation of solid lipid nanoparticles and nanostructured lipid carriers containing zeaxanthin and evaluation of physicochemical properties. Colloids Surfaces A Physicochem Eng Asp 641:128588.
   Web of Science ®Google Scholar
• Patel HP, Gandhi PA, Chaudhari PS, et al. (2021). Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: optimization and in vivo pharmacokinetic studies. J Drug Deliv Sci Technol 64:102533.
   Web of Science ®Google Scholar
• Radwan SAA, El-Maadawy WH, Yousry C, et al. (2020). Zein/phospholipid composite nanoparticles for successful delivery of gallic acid into ahscs: influence of size, surface charge, and vitamin a coupling. Int J Nanomed 15:7995–8018.
   PubMed Web of Science ®Google Scholar
• Rubab S, Naeem K, Rana I, et al. (2021). Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. Int J Pharm 603:120670.
   PubMed Web of Science ®Google Scholar
• Safwat S, Ishak RAH, Hathout RM, Mortada ND. (2017). Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. Drug Dev Ind Pharm 43:1112–25.
   PubMed Web of Science ®Google Scholar
• Sarheed O, Shouqair D, Ramesh K, et al. (2020). Physicochemical characteristics and in vitro permeation of Loratadine solid lipid nanoparticles for transdermal delivery. Ther Deliv 11:685–700.
   PubMed Web of Science ®Google Scholar
• Sayed S, Abdelmoteleb M, Amin MM, Khowessah OM. (2020). Effect of formulation variables and gamma sterilization on transcorneal permeation and stability of proniosomal gels as ocular platforms for antiglaucomal drug. AAPS PharmSciTech 21:1–13.
   Web of Science ®Google Scholar
• Soltani S, Zandi M, Ahmadi SE, et al. (2022). Pooled prevalence estimate of ocular manifestations in COVID-19 patients: a systematic review and meta-analysis. Iran J Med Sci 47:2–14.
   PubMed Web of Science ®Google Scholar
• Spac AF, Grigoriu IC, Ciobanu C, et al. (2016). Validation and application of a RP-HPLC method with UV detection for Loratadine determination. Rev Chim 67:1227–31.
   Web of Science ®Google Scholar
• Suvarna KS, Layton C, Bancroft JD. (2018). Bancroft’s theory and practice of histological techniques. Elsevier Health Sciences.
   Google Scholar
• Sweed NM, Fayez AM, El-Emam SZ, Dawoud MHS. (2021). Response surface optimization of self nano-emulsifying drug delivery system of rosuvastatin calcium for hepatocellular carcinoma. J Pharm Investig 51:85–101.
   Web of Science ®Google Scholar
• Tang Y, Dou R, Liu Y, et al. (2022a). Loratadine-associated cystoid macular edema: a case report. Am J Ophthalmol Case Rep 26:101477.
   PubMedGoogle Scholar
• Tang Z, Fan X, Chen Y, Gu P. (2022b). Ocular nanomedicine. Adv Sci 9:2003699.
   Web of Science ®Google Scholar
• Tasharrofi N, Nourozi M, Marzban A. (2022). How liposomes pave the way for ocular drug delivery after topical administration. J Drug Deliv Sci Technol 67:103045.
   Web of Science ®Google Scholar
• Tavares Luiz M, Santos Rosa Viegas J, Palma Abriata J, et al. (2021). Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. Eur J Pharm Biopharm 165:127–48.
   PubMed Web of Science ®Google Scholar
• Toma I, Tefas LR, Bogdan C, Tomuță I. (2022). Development and characterization of Loratadine liposomal gel using QbD approach. Farmacia 70:204–13.
   Web of Science ®Google Scholar
• Vooturi S, Bourne D, Panda JJ, et al. (2020). Effect of particle size and viscosity of suspensions on topical ocular bioavailability of budesonide, a corticosteroid. J Ocul Pharmacol Ther 36:404–9.
   PubMed Web of Science ®Google Scholar
• Wairkar S, Patel D, Singh A. (2022). Nanostructured lipid carrier based dermal gel of cyclosporine for atopic dermatitis - in vitro and in vivo evaluation. J Drug Deliv Sci Technol 72:103365.
   Web of Science ®Google Scholar
• Walunj M, Doppalapudi S, Bulbake U, Khan W. (2020). Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis. J Liposome Res 30:68–79.
   PubMed Web of Science ®Google Scholar
• Youssef FS, Mohamed GG, Ismail SH, et al. (2021). Synthesis, characterization and in vitro antimicrobial activity of florfenicol-chitosan nanocomposite. Egypt J Chem 64:941–8.
   Web of Science ®Google Scholar
• Zaki RM, Alfadhel MM, Alshahrani SM, et al. (2022). Formulation of chitosan-coated brigatinib nanospanlastics: optimization, characterization, stability assessment and in-vitro cytotoxicity activity against H-1975 cell lines. Pharmaceuticals 15:348.
   Web of Science ®Google Scholar
• Zhang Y, Zhang J, Xu Q, et al. (2021). Simultaneous determination of Loratadine and its metabolite desloratadine in beagle plasma by LC-MS/MS and application for pharmacokinetics study of Loratadine tablets and omeprazole-induced drug–drug interaction. Drug Des Devel Ther 15:5109–22.
   PubMed Web of Science ®Google Scholar
• Zheng J, Shang Y, Wu Y, et al. (2022). Loratadine inhibits Staphylococcus aureus virulence and biofilm formation. IScience 25:103731.
   PubMed Web of Science ®Google Scholar